The pharmacists' awareness, knowledge and attitude about childhood autism in Istanbul

Nimet Emel Luleci1, Seyhan Hidiroglu2, Melda Karavus2

  • 1Department of Public Health, Faculty of Medicine, Marmara University, Başıbüyük Yerleşkesi, Maltepe, 34854, Istanbul, Turkey. emlluleci@gmail.com.

Insights

Pharmacists in Turkey show limited knowledge about autism spectrum disorder (ASD), including outdated beliefs on causes and social stigma. Improving their understanding is crucial for early detection and support for children with ASD.

Area of Science:

  • Healthcare Professional Education
  • Neurodevelopmental Disorders
  • Public Health

Background:

  • Pharmacists are key healthcare providers with potential roles in early autism spectrum disorder (ASD) detection and family support.
  • Familiarity with ASD resources can empower pharmacists to guide families toward appropriate professional help.

Purpose of the Study:

  • To assess pharmacists' awareness, knowledge, and attitudes regarding autism spectrum disorder (ASD).

Main Methods:

  • A descriptive study was conducted with 141 pharmacists in Istanbul, Turkey, using questionnaires.
  • Data collection involved interviews with pharmacists across 7 selected municipalities.

Main Results:

  • Pharmacists' correct answer rates varied from 33.4% to 73.1% across questions.
  • Knowledge gaps were identified regarding ASD causes, with some pharmacists holding outdated beliefs.
  • A significant majority (66.0%) perceived social stigma associated with autism in the community.

Conclusions:

  • Pharmacists' knowledge of ASD requires enhancement.
  • Improving awareness of basic ASD social characteristics can aid pharmacists in referring families to relevant health authorities.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
622
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
308
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
414
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K